Clinical Trial

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Name: SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer — clinical trial record (NCT07125950)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Our study is aimed to evaluate the safety and preliminary of all-oral regimen SHR2554 combined with HRS-8080 or HRS-1358 in advanced breast cancer.

Trial Details

NCT Number	NCT07125950
Lead Sponsor	Henan Cancer Hospital
Conditions	Advanced Breast Cancer
Enrollment	60 participants
Start Date	2025-09-30
Primary Completion	2027-09-30 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-15